Skip to main content

Day: April 6, 2023

EDAP Announces Regulatory Clearance of ExactVu Micro-Ultrasound in Japan

Allows for market launch of the only micro–ultrasound platform for precision prostate biopsies LYON, France, April 6, 2023 — EDAP TMS SA (Nasdaq: EDAP) (“the Company”), a global leader in robotic energy-based therapies, today provided a regulatory and clinical update. The Company has received approval from the Pharmaceutical and Medical Devices Agency (“PMDA”) for the commercialization of the ExactVu™ micro-ultrasound biopsy platform in Japan. “We are pleased to announce the approval of the ExactVu system in Japan,” said Marc Oczachowski, Chief Executive Officer and Chairman of the Board of EDAP TMS. “The Japanese market is the second largest market for advanced medical device technology in the world, and prostate cancer is the most common cancer diagnosis in Japanese men. Each year, there are over 100,000 newly diagnosed...

Continue reading

NanoXplore Appoints Joseph Peter, Former CFO of Nissan Motor Corporation, to Its Board of Directors

MONTREAL, April 06, 2023 (GLOBE NEWSWIRE) — NanoXplore Inc. (“NanoXplore” or “the Corporation”) (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, appointed Mr. Joseph G. Peter as the newest member of its Board of Directors. Mr. Peter brings a wealth of experience and expertise to the Board, having spent more than 35 years working in the automotive industry. He was previously the Chief Financial Officer (CFO) for Nissan Motor Corporation from 2009 to 2018. Prior to joining Nissan, he spent 25 years at General Motors Corporation and served in a number of executive roles including as CFO of General Motors North America and International Operations. As CFO of Nissan, Mr. Peter had a wide-ranging role that encompassed responsibility for the full financial strategy of the company, working closely with operational and regional...

Continue reading

Iris Energy Announces Monthly Investor Update for March 2023

Figure 1 Childress – 345kV substation infrastructureFigure 2 Childress – 20MW data center structural and mechanical installation completeFigure 3 Childress – students at the 4-H robotics clubFigure 4 Childress – high school basketball team attending a Spurs gameDaily average operating hashrate chart Daily average operating hashrate chartOperating capacity increased by 79% to 3.1 EH/s Ramp up on track to 5.5 EH/s 600MW Childress substation nearing energization SYDNEY, Australia, April 06, 2023 (GLOBE NEWSWIRE) — Iris Energy Limited (NASDAQ: IREN) (“Iris Energy” or “the Company”), a leading owner and operator of institutional-grade, highly efficient proprietary Bitcoin mining data centers powered by 100% renewable energy, today published a monthly investor update for March 2023, containing...

Continue reading

Tims China Announces Fourth Quarter and Full Year 2022 Financial Results

Total Revenues Increased 34.6% Year-over-Year for the Fourth Quarter and57.2% Year-over-Year for the Full Year 2022 131 Net New Store Openings During the Fourth Quarter,617 System-Wide Stores at Year-End 11.3 Million Registered Loyalty Club Members at Year-End,Representing 88.5% Year-over-Year Growth Adjusted Store EBITDA Margin Increased 0.6 Percentage Points to 4.7% Continued Recovery: 17.1% Same-store Sales Growth for Company Owned and Operated Stores in February 2023 SHANGHAI and NEW YORK, April 06, 2023 (GLOBE NEWSWIRE) — TH International Limited (Nasdaq: THCH), the exclusive operator of Tim Hortons coffee shops in China (“Tims China” or the “Company”) today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2022. FOURTH QUARTER 2022 HIGHLIGHTSTotal revenues were RMB301.5 million...

Continue reading

Revolution Medicines to Present Preclinical Data at the Upcoming American Association for Cancer Research Annual Meeting 2023

REDWOOD CITY, Calif., April 06, 2023 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced the company and its collaborators will present preclinical data at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2023 being held April 14-19, 2023, in Orlando, Florida. Details of the planned presentations are listed below: Revolution Medicines Oral Presentations:Title:   Discovery of RMC-6291, a tri-complex KRASG12C(ON) inhibitorPresenter:    Jim Cregg, Ph.D.Abstract Number:   ND07Session:    New Drugs on the Horizon: Part 2Date/Time:    3:45 – 4:00 p.m. Eastern on April 16, 2023Title:    RMC-9805, a first-in-class, mutant-selective, covalent and orally bioavailable KRASG12D(ON)...

Continue reading

Parsons to Announce First Quarter 2023 Financial Results on May 3, 2023

CENTREVILLE, Va., April 06, 2023 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE:PSN) will release first quarter 2023 financial results before the markets open on Wednesday, May 3, 2023. The company will host a conference call at 8:00 a.m. Eastern Time that day to discuss its earnings results and strategic corporate initiatives. Access to a webcast of the live conference call can be obtained through the Investor Relations section of the company’s website (www.parsons.com). Participants should go to the website at least 15 minutes before the live event to download and install any necessary audio software. Listeners may also participate in the conference call by dialing +1 833-634-2602 (domestic) or +1 412-902-4114 (international). No passcode is required. A replay will be available on the company’s website approximately...

Continue reading

Verisk Names Chris Sawford Managing Director of Claims for the UK

Supports global insurance market with automated solutions to manage impacts of inflationChris Sawford_Verisk Chris Sawford, managing director of claims for the United Kingdom for VeriskLONDON, April 06, 2023 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, has named Chris Sawford managing director of claims for the United Kingdom. Sawford leads strategic initiatives that can help insurer claims teams boost automation, increase efficiency and contain costs as they continue to face persistently high inflation and supply chain disruption. A sought-after industry expert, Sawford co-founded Validus-IVC, a top provider of claims management solutions in the UK, which Verisk acquired in 2018. “We’re laser-focused on driving operational efficiency and digital transformation for our clients...

Continue reading

Form 8.3 – [The Fulham Shore plc – Opening Declaration – 05 04 2026] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree FULHAM SHORE PLC, THE(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

VOLT LITHIUM ANNOUNCES TECHNICAL BREAKTHROUGH WITH NEXT-GENERATION IES-300 PROPRIETARY DIRECT LITHIUM EXTRACTION PROCESS

Vancouver, British Columbia, Canada, April 06, 2023 (GLOBE NEWSWIRE) — Allied Copper Corp. (TSX-V: CPR, OTCQB: CPRRF, FSE: S9G) (“Allied”), is pleased to announce that its lithium-focused division, Volt Lithium Corp (“Volt” or the “Company”) has achieved a technical breakthrough with its proprietary, next-generation IES-300 Direct Lithium Extraction (“DLE”) technology, which is expected to support continued step-change improvements in Volt’s process and project economics upon commercialization. This next-level IES-300 technology builds on the previously announced success of Volt’s original IES-200 DLE process, which achieved 93% lithium recoveries from oilfield brines. With IES-300, the Company has continued to realize up to 93% lithium extraction, while also reducing the amount of re-agent required to treat oilfield brine as it...

Continue reading

Form 8.3 – [Devro plc – 05 04 2023] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree DEVRO PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.